Long-term melatonin or 17beta-estradiol supplementation alleviates oxidative stress in ovariectomized adult rats.

Melatonin is an endogenously generated potent antioxidant. Our previous results indicated that melatonin improved learning and memory deficits in the transgenic mouse model of Alzheimer's disease (AD) and ovariectomized (OVX) rats by improving cholinergic nerve system dysfunction, preventing apoptosis. In this study we aim to investigate the antioxidative effects of melatonin or estradiol in the brains of ovariectomized rats. OVX Sprague-Dawley rats received daily injections of melatonin (5, 10, or 20 mg/kg), 17beta-estradiol (80 microg/kg), or sesame oil for 16 weeks. We found an increase in brain mitochondrial thiobarbituric acid-reactive substances (TBARS) levels, a decrease in mitochondrial glutathione (GSH) content as well as mitochondrial superoxide dismutase (SOD) activity and upregulation of the apoptotic-related factors, such as Bax, Caspase-3, and Prostate apoptosis response-4 (Par-4) in the frontal cortex of OVX rats. In addition to oxidative stress, OVX also caused decreased activities of mitochondrial respiration complex I and complex IV, which implicated mitochondrial dysfunction. Melatonin or 17beta-estradiol antagonized the detrimental effects induced by OVX. Furthermore, immunohistochemistry results revealed that the abnormal upregulation of the apoptotic related factor such as Bax, Caspase-3, and (Par-4) greatly reduced expression after melatonin or 17beta-estradiol supplement action. These findings demonstrate the important effects of melatonin or 17beta-estradiol on postmenopausal neuropathy and support the potential application of melatonin in the treatment of dementia in postmenopausal women. Early, long-term melatonin application is a promising strategy which could potentially be applied in a clinical setting.

[1]  H. H. Draper,et al.  Malondialdehyde determination as index of lipid peroxidation. , 1990, Methods in enzymology.

[2]  C. Cotman,et al.  Estrogen regulates bcl-x expression in rat hippocampus , 2001, Neuroreport.

[3]  A. Cagnacci,et al.  Different circulatory response to melatonin in postmenopausal women without and with hormone replacement therapy , 2000, Journal of pineal research.

[4]  A. Wakatsuki,et al.  Effects of short-term melatonin administration on lipoprotein metabolism in normolipidemic postmenopausal women. , 2001, Maturitas.

[5]  C. Iadecola,et al.  Estrogen provides neuroprotection in transient forebrain ischemia through perfusion-independent mechanisms in rats. , 1999, Stroke.

[6]  F. Paoletti,et al.  Determination of superoxide dismutase activity by purely chemical system based on NAD(P)H oxidation. , 1990, Methods in enzymology.

[7]  Koh-ich Tanaka,et al.  Effects of ovariectomy and calcium deficiency on learning and memory of eight-arm radial maze in middle-aged female rats , 2003, Behavioural Brain Research.

[8]  L. Doncarlos,et al.  Neuroprotection by estradiol , 2001, Progress in Neurobiology.

[9]  A. Levine,et al.  Estrogen replacement therapy: effects on the cognitive functioning and clinical course of women with Alzheimer's disease. , 2004, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[10]  T. Horvath,et al.  Estrogen, synaptic plasticity and hypothalamic reproductive aging , 2003, Experimental Gerontology.

[11]  C. Behl,et al.  Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach. , 2002, Free radical biology & medicine.

[12]  S. Xia,et al.  The Estrogen Receptor Is Not Essential for All Estrogen Neuroprotection: New Evidence from a New Analog , 2002, Neurobiology of Disease.

[13]  D. Barber,et al.  17β-oestradiol attenuates dexamethasone-induced lethal and sublethal neuronal damage in the striatum and hippocampus , 2003, Neuroscience.

[14]  K. Beck,et al.  Estradiol Enhances Learning and Memory in a Spatial Memory Task and Effects Levels of Monoaminergic Neurotransmitters , 1998, Hormones and Behavior.

[15]  Yong Cheng,et al.  Long‐term effects of melatonin or 17β‐estradiol on improving spatial memory performance in cognitively impaired, ovariectomized adult rats , 2004, Journal of pineal research.

[16]  D. Acuña-Castroviejo,et al.  Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria. , 2002, The international journal of biochemistry & cell biology.

[17]  R. Reiter,et al.  Melatonin‐induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo , 2000, Journal of pineal research.

[18]  P. Anninos,et al.  Is postmenopausal osteoporosis related to pineal gland functions? , 1992, The International journal of neuroscience.

[19]  Zheng Feng,et al.  Protective effect of melatonin on β-amyloid-induced apoptosis in rat astroglioma c6 cells and its mechanism , 2004 .

[20]  B. Sherwin,et al.  Estrogen and cognitive functioning in women. , 2003, Endocrine reviews.

[21]  Roberta Diaz Brinton,et al.  Mechanism of estrogen-mediated neuroprotection: Regulation of mitochondrial calcium and Bcl-2 expression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  K. Hensley,et al.  Oxidative stress in brain aging Implications for therapeutics of neurodegenerative diseases , 2002, Neurobiology of Aging.

[23]  M. Segal,et al.  Brain-derived neurotrophic factor mediates estradiol-induced dendritic spine formation in hippocampal neurons. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[24]  D. Acuña-Castroviejo,et al.  Mitochondrial regulation by melatonin and its metabolites. , 2003, Advances in experimental medicine and biology.

[25]  C. Woolley,et al.  Estradiol Increases the Sensitivity of Hippocampal CA1 Pyramidal Cells to NMDA Receptor-Mediated Synaptic Input: Correlation with Dendritic Spine Density , 1997, The Journal of Neuroscience.

[26]  Sanjay Asthana,et al.  Estrogen and Alzheimer’s Disease , 2002, Drugs & aging.

[27]  Koji Abe,et al.  Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease , 2003, Journal of neurochemistry.

[28]  N. J. Sandstrom,et al.  Memory retention is modulated by acute estradiol and progesterone replacement. , 2001, Behavioral neuroscience.

[29]  Rehema M. White,et al.  Estrogenic effects on urinary 6‐sulphatoxymelatonin excretion in the female rat , 1997, Journal of pineal research.

[30]  C. Behl.  Oestrogen as a neuroprotective hormone , 2002, Nature Reviews Neuroscience.

[31]  C. Kooperberg,et al.  Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. , 2003, JAMA.

[32]  E. Melamed,et al.  Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier , 2001, Neuropharmacology.

[33]  Zheng Feng,et al.  Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease , 2004, Journal of pineal research.

[34]  F. Bayraktar,et al.  The Effects of Estrogen and Raloxifene Treatment on Antioxidant Enzymes in Brain and Liver of Ovarectomized Female Rats , 2003, Endocrine research.

[35]  J. Simpkins,et al.  Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[36]  I. Merchenthaler,et al.  Estrogen is More Than just a “Sex Hormone”: Novel Sites for Estrogen Action in the Hippocampus and Cerebral Cortex , 2000, Frontiers in Neuroendocrinology.

[37]  H. Handa,et al.  On the isolation of mitochondria with high respiratory control from rat brain. , 1966, Journal of biochemistry.

[38]  W. Millard,et al.  Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats , 1994, Brain Research.

[39]  P. Chyka,et al.  Problems in assessment of acute melatonin overdose. , 1997, Southern medical journal.

[40]  P. Greengard,et al.  Estrogen alters hippocampal dendritic spine shape and enhances synaptic protein immunoreactivity and spatial memory in female mice , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Spasić,et al.  Effects of progesterone and estradiol benzoate on glutathione dependent antioxidant enzyme activities in the brain of female rats. , 1999, General physiology and biophysics.

[42]  R. S. Sohal,et al.  Relationship between mitochondrial superoxide and hydrogen peroxide production and longevity of mammalian species. , 1993, Free radical biology & medicine.

[43]  R. Reiter,et al.  Melatonin as a Pharmacological Agent against Neuronal Loss in Experimental Models of Huntington's Disease, Alzheimer's Disease and Parkinsonism , 1999, Annals of the New York Academy of Sciences.

[44]  N. Rasgon,et al.  Reproductive events modify the effects of estrogen replacement therapy on cognition in healthy postmenopausal women , 2005, Psychoneuroendocrinology.

[45]  L. Mello,et al.  Estrogen, progestogen and tamoxifen increase synaptic density of the hippocampus of ovariectomized rats , 2000, Neuroscience Letters.

[46]  Zheng Feng,et al.  Melatonin reduces amyloid β‐induced apoptosis in pheochromocytoma (PC12) cells , 2004 .

[47]  J. Morrison,et al.  Cyclic Estrogen Replacement Improves Cognitive Function in Aged Ovariectomized Rhesus Monkeys , 2003, The Journal of Neuroscience.

[48]  Jun Xie,et al.  Prostate Apoptosis Response-4 Enhances Secretion of Amyloid β Peptide 1–42 in Human Neuroblastoma IMR-32 Cells by a Caspase-dependent Pathway* , 2001, The Journal of Biological Chemistry.

[49]  P. Wise,et al.  Minireview: Neuroprotective Effects of Estrogen-New Insights into Mechanisms of Action. , 2001, Endocrinology.

[50]  M. Mattson,et al.  Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1. , 1997, Neuroreport.

[51]  A. Hofman,et al.  Endogenous estradiol and risk of dementia in women and men: The Rotterdam Study , 2003, Annals of neurology.

[52]  H. Tanila,et al.  Effects of Ovariectomy and Estrogen Treatment on Learning and Hippocampal Neurotransmitters in Mice , 2002, Hormones and Behavior.

[53]  B. Bhavnani.  Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer’s , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[54]  C. Behl,et al.  The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[55]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[56]  V. H. Cohn,et al.  A fluorometric assay for glutathione. , 1966, Analytical biochemistry.

[57]  S. Shimohama,et al.  Mechanisms of antiapoptotic effects of estrogens in nigral dopaminergic neurons , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[58]  George Perry,et al.  The neuroprotective activities of melatonin against the Alzheimer β‐protein are not mediated by melatonin membrane receptors , 2002, Journal of pineal research.

[59]  S. Asthana,et al.  Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer’s disease: results of a placebo-controlled, double-blind, pilot study , 1999, Psychoneuroendocrinology.

[60]  Federico V Pallardó,et al.  The role of mitochondrial oxidative stress in aging. , 2003, Free radical biology & medicine.

[61]  R. Moreno-Sánchez,et al.  Inhibition of substrate oxidation in mitochondria by the peripheral-type benzodiazepine receptor ligand AHN 086. , 1991, Biochemical pharmacology.

[62]  P. Waldmeier.  Prospects for antiapoptotic drug therapy of neurodegenerative diseases , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[63]  S. Asthana,et al.  High-dose estradiol improves cognition for women with AD , 2001, Neurology.

[64]  G. Hoffman.  Ambiguity of estrogen receptor antagonists: good guys don't always wear white hats… or do they? , 2004, Experimental Neurology.